These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 19440558

  • 1. Biomarkers for Alzheimer's disease.
    Pauwels EK, Volterrani D, Mariani G.
    Drug News Perspect; 2009 Apr; 22(3):151-60. PubMed ID: 19440558
    [Abstract] [Full Text] [Related]

  • 2. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
    Weise D, Tiepolt S, Awissus C, Hoffmann KT, Lobsien D, Kaiser T, Barthel H, Sabri O, Gertz HJ.
    J Alzheimers Dis; 2015 Apr; 48(2):425-32. PubMed ID: 26402006
    [Abstract] [Full Text] [Related]

  • 3. Dissociation of amyloid biomarkers in PET and CSF in Alzheimer's disease: a case report.
    Schroeter ML, Tiepolt S, Marschhauser A, Thöne-Otto A, Hoffmann KT, Barthel H, Obrig H, Sabri O.
    BMC Neurol; 2015 Aug 26; 15():152. PubMed ID: 26303364
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
    Kang JH, Vanderstichele H, Trojanowski JQ, Shaw LM.
    Methods; 2012 Apr 26; 56(4):484-93. PubMed ID: 22503777
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
    Morinaga A, Ono K, Ikeda T, Ikeda Y, Shima K, Noguchi-Shinohara M, Samuraki M, Yanase D, Yoshita M, Iwasa K, Mastunari I, Yamada M.
    Dement Geriatr Cogn Disord; 2010 Apr 26; 30(4):285-92. PubMed ID: 20861634
    [Abstract] [Full Text] [Related]

  • 6. Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.
    Schaffer C, Sarad N, DeCrumpe A, Goswami D, Herrmann S, Morales J, Patel P, Osborne J.
    J Lab Autom; 2015 Oct 26; 20(5):589-600. PubMed ID: 25424384
    [Abstract] [Full Text] [Related]

  • 7. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Sarlus H, Eyjolfsdottir H, Eriksdotter M, Oprica M, Schultzberg M.
    J Alzheimers Dis; 2015 Oct 26; 48(2):495-505. PubMed ID: 26402013
    [Abstract] [Full Text] [Related]

  • 8. Markers of Alzheimer's disease in a population attending a memory clinic.
    Frisoni GB, Prestia A, Zanetti O, Galluzzi S, Romano M, Cotelli M, Gennarelli M, Binetti G, Bocchio L, Paghera B, Amicucci G, Bonetti M, Benussi L, Ghidoni R, Geroldi C.
    Alzheimers Dement; 2009 Jul 26; 5(4):307-17. PubMed ID: 19560101
    [Abstract] [Full Text] [Related]

  • 9. The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.
    Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonça A, Didic M, Eriksdotter M, Félician O, Frölich L, Gertz HJ, Hallikainen M, Hasselbalch SG, Hausner L, Heuser I, Jessen F, Jones RW, Kurz A, Lawlor B, Lleo A, Martinez-Lage P, Mecocci P, Mehrabian S, Monsch A, Nobili F, Nordberg A, Rikkert MO, Orgogozo JM, Pasquier F, Peters O, Salmon E, Sánchez-Castellano C, Santana I, Sarazin M, Traykov L, Tsolaki M, Visser PJ, Wallin ÅK, Wilcock G, Wilkinson D, Wolf H, Yener G, Zekry D, Frisoni GB.
    Alzheimers Dement; 2015 Feb 26; 11(2):195-206.e1. PubMed ID: 25150733
    [Abstract] [Full Text] [Related]

  • 10. Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.
    Brys M, Pirraglia E, Rich K, Rolstad S, Mosconi L, Switalski R, Glodzik-Sobanska L, De Santi S, Zinkowski R, Mehta P, Pratico D, Saint Louis LA, Wallin A, Blennow K, de Leon MJ.
    Neurobiol Aging; 2009 May 26; 30(5):682-90. PubMed ID: 17889968
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S.
    J Med Assoc Thai; 2011 Feb 26; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [Abstract] [Full Text] [Related]

  • 17. Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's disease.
    Parnetti L, Chiasserini D.
    Biomark Med; 2011 Aug 26; 5(4):479-84. PubMed ID: 21861669
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.